In a CD-HFD model of NASH, Wolf et al. could also describe metabolically activated CD8 T cells, monitored by CD44 and CD69 upregulation (Wolf et al., 2014), underlining that CD8 T cells could play a pro-inflammatory role in metabolic liver disease. This evidence concerns the gene CD44 and metabolic dysfunction-associated steatohepatitis.